NCT04817553View on ClinicalTrials.gov

Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients

CompletedOBSERVATIONAL
Enrollment

124

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

January 10, 2023

Study Completion Date

January 10, 2023

Conditions
IgG4 Related DiseaseCovid19
Interventions
OTHER

exposure to COVID19

Observational study of IgG4 patients with pancreatobiliary involvement who were diagnosed with COVID19

Trial Locations (1)

Unknown

Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT04817553 - Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients | Biotech Hunter | Biotech Hunter